169 related articles for article (PubMed ID: 36458958)
1. Positron Emission Tomography Assessments of Phosphodiesterase 10A in Patients With Schizophrenia.
Kubota M; Takahata K; Matsuoka K; Sano Y; Yamamoto Y; Tagai K; Tarumi R; Suzuki H; Kurose S; Nakajima S; Shiwaku H; Seki C; Kawamura K; Zhang MR; Takahashi H; Takado Y; Higuchi M
Schizophr Bull; 2023 May; 49(3):688-696. PubMed ID: 36458958
[TBL] [Abstract][Full Text] [Related]
2. Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study.
Bodén R; Persson J; Wall A; Lubberink M; Ekselius L; Larsson EM; Antoni G
Transl Psychiatry; 2017 Mar; 7(3):e1050. PubMed ID: 28267149
[TBL] [Abstract][Full Text] [Related]
3. Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D
Fazio P; Schain M; Mrzljak L; Amini N; Nag S; Al-Tawil N; Fitzer-Attas CJ; Bronzova J; Landwehrmeyer B; Sampaio C; Halldin C; Varrone A
Neuroimage; 2017 May; 152():330-339. PubMed ID: 28254508
[TBL] [Abstract][Full Text] [Related]
4. Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.
Niccolini F; Foltynie T; Reis Marques T; Muhlert N; Tziortzi AC; Searle GE; Natesan S; Kapur S; Rabiner EA; Gunn RN; Piccini P; Politis M
Brain; 2015 Oct; 138(Pt 10):3003-15. PubMed ID: 26210536
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase 10A levels are related to striatal function in schizophrenia: a combined positron emission tomography and functional magnetic resonance imaging study.
Persson J; Szalisznyó K; Antoni G; Wall A; Fällmar D; Zora H; Bodén R
Eur Arch Psychiatry Clin Neurosci; 2020 Jun; 270(4):451-459. PubMed ID: 31119377
[TBL] [Abstract][Full Text] [Related]
6. In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [
Svedberg MM; Varnäs K; Varrone A; Mitsios N; Mulder J; Gulyás B; Beaumont V; Munoz-Sanjuan I; Zaleska MM; Schmidt CJ; Halldin C; Mrzljak L
Brain Res; 2019 May; 1711():140-145. PubMed ID: 30664847
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiesterase 10A in Schizophrenia: A PET Study Using [(11)C]IMA107.
Marques TR; Natesan S; Niccolini F; Politis M; Gunn RN; Searle GE; Howes O; Rabiner EA; Kapur S
Am J Psychiatry; 2016 Jul; 173(7):714-21. PubMed ID: 26892941
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [¹¹C]MP-10 PET rodent imaging study with ex vivo confirmation.
Natesan S; Ashworth S; Nielsen J; Tang SP; Salinas C; Kealey S; Lauridsen JB; Stensbøl TB; Gunn RN; Rabiner EA; Kapur S
Transl Psychiatry; 2014 Apr; 4(4):e376. PubMed ID: 24690597
[TBL] [Abstract][Full Text] [Related]
9. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
[TBL] [Abstract][Full Text] [Related]
10. In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654.
Barret O; Thomae D; Tavares A; Alagille D; Papin C; Waterhouse R; McCarthy T; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
J Nucl Med; 2014 Aug; 55(8):1297-304. PubMed ID: 24898025
[TBL] [Abstract][Full Text] [Related]
11. Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [(11)C]T-773.
Tóth M; Häggkvist J; Stepanov V; Takano A; Nakao R; Amini N; Miura S; Kimura H; Taniguchi T; Gulyás B; Halldin C
Mol Imaging Biol; 2015 Aug; 17(4):445-9. PubMed ID: 25622810
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject.
Liu H; Jin H; Yue X; Zhang X; Yang H; Li J; Flores H; Su Y; Perlmutter JS; Tu Z
Neuroimage; 2015 Nov; 121():253-62. PubMed ID: 26216275
[TBL] [Abstract][Full Text] [Related]
13. Translational Development Strategies for TAK-063, a Phosphodiesterase 10A Inhibitor.
Macek TA; Suzuki K; Asin K; Kimura H
Int J Neuropsychopharmacol; 2020 Nov; 23(8):524-532. PubMed ID: 32598478
[TBL] [Abstract][Full Text] [Related]
14. Effects of a novel phosphodiesterase 10A inhibitor in non-human primates: A therapeutic approach for schizophrenia with improved side effect profile.
Masilamoni GJ; Uthayathas S; Koenig G; Leventhal L; Papa SM
Neuropharmacology; 2016 Nov; 110(Pt A):449-457. PubMed ID: 27539962
[TBL] [Abstract][Full Text] [Related]
15. The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease.
Russell DS; Barret O; Jennings DL; Friedman JH; Tamagnan GD; Thomae D; Alagille D; Morley TJ; Papin C; Papapetropoulos S; Waterhouse RN; Seibyl JP; Marek KL
JAMA Neurol; 2014 Dec; 71(12):1520-8. PubMed ID: 25322077
[TBL] [Abstract][Full Text] [Related]
16. Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers.
Wilson H; Niccolini F; Haider S; Marques TR; Pagano G; Coello C; Natesan S; Kapur S; Rabiner EA; Gunn RN; Tabrizi SJ; Politis M
J Neurol Sci; 2016 Sep; 368():243-8. PubMed ID: 27538642
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic voluntary alcohol consumption on PDE10A availability: a longitudinal behavioral and [
de Laat B; Kling YE; Schroyen G; Ooms M; Hooker JM; Bormans G; Van Laere K; Ceccarini J
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):492-502. PubMed ID: 34142214
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A.
Harada A; Suzuki K; Miura S; Hasui T; Kamiguchi N; Ishii T; Taniguchi T; Kuroita T; Takano A; Stepanov V; Halldin C; Kimura H
Nucl Med Biol; 2015 Feb; 42(2):146-54. PubMed ID: 25451212
[TBL] [Abstract][Full Text] [Related]
20. Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates.
Hwang DR; Hu E; Rumfelt S; Easwaramoorthy B; Castrillon J; Davis C; Allen JR; Chen H; Treanor J; Abi-Dargham A; Slifstein M
Nucl Med Biol; 2014 Apr; 41(4):343-9. PubMed ID: 24607437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
